NCT07232017 Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
| NCT ID | NCT07232017 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anita Misra-Hebert |
| Condition | Hypertension (HTN) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,520 participants |
| Start Date | 2026-01-06 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,520 participants in total. It began in 2026-01-06 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Eligibility Criteria
Inclusion Criteria: * Hypertension diagnosis, aged 18-85 years old * Uncontrolled blood pressure, defined as a blood pressure reading of \> 150/95 Exclusion Criteria: * pregnant, stage 5 chronic kidney disease, End Stage Renal Disease, enrolled in hospice care
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07232017 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Hypertension (HTN). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07232017 currently recruiting?
Yes, NCT07232017 is actively recruiting participants. Contact the research team at MISRAA@ccf.org for enrollment information.
Where is the NCT07232017 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07232017 clinical trial?
NCT07232017 is sponsored by Anita Misra-Hebert. The trial plans to enroll 1,520 participants.